TMO vs INCY
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Incyte Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | INCY |
|---|---|---|
| Price | $700.22 | $120.97 |
| Market cap | $259.44B | $24.66B |
| P/E ratio | 36.9 | 61.7 |
| ROE | 13.38% | 7.84% |
| Profit margin | 14.94% | 6.71% |
| Revenue growth | 9.10% | 14.00% |
| Dividend yield | 0.27% | 0.00% |
| Beta | 0.84 | 0.78 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs INCY in plain English
- TMO is the bigger company — about 10.5× the market cap of INCY.
- TMO is cheaper on earnings (P/E 36.9 vs 61.7).
- TMO earns a higher return on equity (13% vs 8%).
- INCY is growing revenue faster (14% vs 9%).
- TMO pays a dividend (0.27%) while the other effectively doesn't.
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
INCY return calculator
See what $1,000 in Incyte Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.